PPARβ/δ activation evidently causes psoriasis-like disease not solely through STAT3 activation since (i) the phenotype is not completely reversed by inhibition of STAT3 and (ii) overexpression of STAT3 alone causes a less widespread psoriasis-like phenotype with a much longer latency [34]. The gene discussed is STAT3; the disease is psoriasis.